Diabetes is a risk factor for cognitive decline. In a study of the University of Turku and Finnish Institute for
Day: September 18, 2021
COVID-19 vaccine booster dose cuts infection in those 60 and older
Among Israeli adults aged 60 years and older, those receiving a third booster dose of the Pfizer-BioNTech COVID-19 vaccine have
Vaccine nasal sprays aim to ‘shut door’ on virus
Could delivering Covid-19 immunity directly to the nose—the area of the body via which it is most likely to be
HER2-targeting antibody-drug improves progression-free survival for women with deadly form of advanced breast cancer
A study led by researchers at the UCLA Jonsson Comprehensive Cancer Center has found that treating women with HER2 positive
Greater, broader SARS-CoV-2 neutralizing antibodies with third dose of vaccine
A third dose of the Pfizer-BioNTech vaccine significantly increased neutralizing antibody levels against SARS-CoV-2, the virus that causes COVID-19, according
US govt advisers vote no to Pfizer Covid boosters for ages 16 and up
Leading US medical experts advising the government voted against recommending booster doses of Pfizer’s Covid-19 vaccine for everyone aged 16
US panel backs COVID-19 boosters only for seniors, high-risk
Dealing the White House a stinging setback, a government advisory panel overwhelmingly rejected a plan Friday to give Pfizer COVID-19
Discovery highlights the complex lifestyles of frontline immune cells
WEHI researchers have made a surprise discovery about how immune ‘sentinel’ cells are maintained, which could have implications for drugs
Infants exposed to domestic violence have poorer cognitive development
While assessing a pregnant woman with premature labor in 1983, Linda Bullock noticed bruises on the woman. When she asked
Allergies to mRNA-based COVID-19 vaccines rare, generally mild, study finds
Allergic reactions to the new mRNA-based COVID-19 vaccines are rare, typically mild and treatable, and they should not deter people
